STING1 and gastric cancer: Additionally, a study by Gao et al. identified prognosis and immunotherapy biomarkers (M2GO), including STING downstream molecules TBK1 and IRF3, utilizing transcriptome sequencing data from clinical gastric cancer patients with ovarian metastasis, which were externally validated using the TCGA-STAD database.